Loading...
XHKG
8372
Market cap12mUSD
Jun 27, Last price  
0.12HKD
1D
-5.60%
1Q
6.31%
IPO
-64.24%
Name

Grand Brilliance Group Holdings Ltd

Chart & Performance

D1W1MN
P/E
12.02
P/S
1.15
EPS
0.01
Div Yield, %
2.12%
Shrs. gr., 5y
Rev. gr., 5y
7.13%
Revenues
82m
+6.78%
52,876,00051,657,00053,703,00058,045,00067,227,00070,241,00071,978,00076,701,00081,903,000
Net income
8m
+3.87%
12,979,00011,802,000-3,080,0006,608,0009,566,0007,859,0004,048,0007,562,0007,855,000
CFO
7m
-46.93%
15,908,0004,747,0003,296,000-3,177,00021,625,0006,012,000-3,334,00012,658,0006,718,000
Dividend
Jul 15, 20240.0025 HKD/sh

Profile

Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. It offers medical consumables; medical instruments; and medical equipment, as well as develops healthcare products. The company also provides medical device solutions, such as market trend analysis, sourcing of medical devices, after-sale services, technical support and training services, medical devices leasing services, and quality assurance services; and maintenance services, as well as holds trademarks. It sells its products to various private and public hospitals, private clinics, non-profit organizations, universities, and individual end-users. The company was founded in 1997 and is based in Tsuen Wan, Hong Kong. Grand Brilliance Group Holdings Limited is a subsidiary of B&A Success Limited.
IPO date
Mar 29, 2018
Employees
41
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
81,903
6.78%
76,701
6.56%
Cost of revenue
80,715
71,349
Unusual Expense (Income)
NOPBT
1,188
5,352
NOPBT Margin
1.45%
6.98%
Operating Taxes
420
1,815
Tax Rate
35.35%
33.91%
NOPAT
768
3,537
Net income
7,855
3.87%
7,562
86.81%
Dividends
(3,200)
(2,400)
Dividend yield
4.23%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,429
3,766
Long-term debt
1,429
5,142
Deferred revenue
Other long-term liabilities
Net debt
(61,522)
(57,522)
Cash flow
Cash from operating activities
6,718
12,658
CAPEX
(1,804)
(63)
Cash from investing activities
(395)
(510)
Cash from financing activities
(7,420)
(6,399)
FCF
(4,563)
5,230
Balance
Cash
60,466
61,858
Long term investments
3,914
4,572
Excess cash
60,285
62,595
Stockholders' equity
48,285
44,672
Invested Capital
56,420
58,033
ROIC
1.34%
6.07%
ROCE
1.13%
5.21%
EV
Common stock shares outstanding
800,000
800,000
Price
0.07
-5.33%
Market cap
56,800
-5.33%
EV
(722)
EBITDA
5,804
9,718
EV/EBITDA
Interest
106
152
Interest/NOPBT
8.92%
2.84%